Abstract
IgA1 protease of Streptococcus suis serotype 2 (SS2) has been proven to be relative with virulence and immunogenicity, however, its protective efficacy remained to be evaluated. The present study found evidence that immunization with purified recombinant IgA1 protease (600-1926aa) could induce high IgG antibody titers and could confer complete protection against a challenge with a lethal dose of SS2 in a mouse model. In addition, our findings confirmed that the IgA1 protease distributes on the surface of SS2. Therefore, the present study identified the virulence-associated protein, IgA1 protease, as a novel surface protective antigen of SS2.
Keywords:
IgA1 protease; Protective antigen; Streptococcus suis.
Copyright © 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Bacterial / blood*
-
Antigens, Bacterial / immunology*
-
Disease Models, Animal
-
Membrane Proteins / immunology
-
Mice, Inbred BALB C
-
Serine Endopeptidases / immunology*
-
Serogroup
-
Streptococcal Infections / immunology
-
Streptococcal Infections / prevention & control*
-
Streptococcal Vaccines / administration & dosage
-
Streptococcal Vaccines / genetics
-
Streptococcal Vaccines / immunology*
-
Streptococcus suis / classification
-
Streptococcus suis / enzymology*
-
Streptococcus suis / immunology*
-
Vaccines, Synthetic / administration & dosage
-
Vaccines, Synthetic / genetics
-
Vaccines, Synthetic / immunology
Substances
-
Antibodies, Bacterial
-
Antigens, Bacterial
-
Membrane Proteins
-
Streptococcal Vaccines
-
Vaccines, Synthetic
-
Serine Endopeptidases
-
IgA-specific serine endopeptidase